MoonLake Immunotherapeutics (MEX:MLTXN) OCF Yield %: -13.41 (As of Jun. 26, 2026)


MEX:MLTXN MoonLake Immunotherapeutics MEX:MLTXN
30 GF Score
Price MXN305.30
! 3 Warning Signs
View Full Analysis

What is MoonLake Immunotherapeutics OCF Yield %?

MoonLake Immunotherapeutics MEX:MLTXN 30 OCF Yield % is -13.41 as of Jun. 26, 2026. GuruFocus rates MEX:MLTXN with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 1,419 Biotechnology companies, MoonLake Immunotherapeutics ranks worse than 62.72% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, MoonLake Immunotherapeutics's Trailing 12-Month Cash Flow from Operations is MXN-4,097.81 Mil, and Market Cap is MXN29,477.41 Mil. Therefore, MoonLake Immunotherapeutics's OCF Yield % for today is -13.41%.

The historical rank and industry rank for MoonLake Immunotherapeutics's OCF Yield % or its related term are showing as below:

MEX:MLTXN' s OCF Yield % Range Over the Past 10 Years
Min: -13.41   Med: 0   Max: -13.41
Current: -13.41

During the past 5 years, the highest OCF Yield % of MoonLake Immunotherapeutics was -13.41%. The lowest was -13.41%. And the median was %.

MEX:MLTXN's OCF Yield % is ranked worse than
62.72% of 1419 companies
in the Biotechnology industry
Industry Median: -8.48 vs MEX:MLTXN: -13.41

MoonLake Immunotherapeutics's OCF Margin % for the quarter that ended in Mar. 2026 was %.

MoonLake Immunotherapeutics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

MoonLake Immunotherapeutics OCF Yield % Related Terms

MoonLake Immunotherapeutics OCF Yield % Historical Data

* Premium members only.

The historical data trend for MoonLake Immunotherapeutics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MoonLake Immunotherapeutics OCF Yield % Chart

MoonLake Immunotherapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
0.00 0.00 -1.60 -3.59 -4.60

MoonLake Immunotherapeutics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.58 -6.02 -4.78 -5.52 -21.71

MEX:MLTXN vs AVBP, BCAX, KALV: OCF Yield % Comparison

For the Biotechnology subindustry, MoonLake Immunotherapeutics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MoonLake Immunotherapeutics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MoonLake Immunotherapeutics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where MoonLake Immunotherapeutics's OCF Yield % falls into.


MEX:MLTXN
30GF Score
MoonLake Immunotherapeutics MEX:MLTXN
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MoonLake Immunotherapeutics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

MoonLake Immunotherapeutics's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-3529.243 / 76669.9508
=-4.60%

MoonLake Immunotherapeutics's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1195.316 * 4 / 22022.5102
=-21.71%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -13.41 mean?
MoonLake Immunotherapeutics (MEX:MLTXN) has a OCF Yield % of -13.41 as of Jun. 26, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MoonLake Immunotherapeutics and its competitors. According to the industry distribution chart, MoonLake Immunotherapeutics ranks #890 out of 1419 companies in the Biotechnology industry, placing it in the top 62.7%.
Is MoonLake Immunotherapeutics' OCF Yield % too high?
MoonLake Immunotherapeutics' current OCF Yield % is -13.41. Based on the distribution chart, MoonLake Immunotherapeutics ranks #890 out of 1419 companies in the Biotechnology industry, which is below the industry midpoint. Overall, MoonLake Immunotherapeutics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does MoonLake Immunotherapeutics' OCF Yield % compare to AVBP and BCAX?
According to the Biotechnology industry distribution chart, MoonLake Immunotherapeutics ranks #890 out of 1419 companies for OCF Yield %. This places MoonLake Immunotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on MoonLake Immunotherapeutics and its competitors. MoonLake Immunotherapeutics's current OCF Yield % is -13.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MoonLake Immunotherapeutics stock overvalued right now?
MoonLake Immunotherapeutics (MEX:MLTXN) has a current OCF Yield % of -13.41. The current OCF Yield % is -13.41. MoonLake Immunotherapeutics' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For MoonLake Immunotherapeutics (MEX:MLTXN), the current OCF Yield % is -13.41 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MoonLake Immunotherapeutics Business Description

Other Exchanges MLTX:USA
Address Dorfstrasse 29, Zug, CHE, 6300
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
30GF Score

Get the complete analysis for MEX:MLTXN

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.30
Price